Fufang Xue Shuan tong capsules inhibit renal oxidative stress markers and indices of nephropathy in diabetic rats

Experimental and Therapeutic Medicine

Volumn 4, Issue 5, 2012, Pages 871-876

  Fang, Donghong ^a   Wan, Xuesi ^a   Deng, Wanping ^a   Guan, Hongyu ^a   Ke, Weijian ^a   Xiao, Haipeng ^a   Li, Yanbing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Fufang Xue Shuan tong capsule; Malondialdehyde; Oxidative stress; Superoxide dismutase

Indexed keywords

ANTIDIABETIC AGENT; CAPTOPRIL; CHINESE DRUG; CREATININE; FUFANG XUE SHUAN TONG; GLUCOSE; MALONALDEHYDE; PROTEIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG CAPSULE; DRUG MEGADOSE; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; KIDNEY CORTEX; KIDNEY HYPERTROPHY; KIDNEY MASS; LIPID DIET; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; TREATMENT DURATION; URINARY EXCRETION;

EID: 84866354588     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.680     Document Type: Article

References (22)

1. American Diabetes Assocation: Standards of medical care in diabetes - 2011. Diabetes Care 34 (Suppl 1): 11-61, 2011.
2. Zhang J, Huang Q, Liu Y, et al: Effect of complex dribbing-pill of xue shuan tong on thrombus formation and microcirculation in rat. Zhong Yao Cai 26: 881-882, 2003.
3. Ye XF and Xu GZ: Effect of Fufang Xue Shuan Tong on retinal oxidative stress in diabetic rats. Chin J Oeul Fundus Dis 26: 176-178, 2010.
4. Skrha J, Hodinar A, Kvasnicka J and Hilgertova J: Relationship of oxidative stress and fibrinolysis in diabetes mellitus. Diabet Med 13: 800-805, 1996.
5. De Mattia G, Bravi MC, Laurenti O, et al: Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes. Diabetologia 41: 1392-1396, 1998
6. Ihara Y, Toyokuni S, Uchida K, et al: Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48: 927-932, 1999.
7. Pan HZ, Zhang L, Guo MY, et al: The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol 47: 71-76, 2010.
8. Nam SM, Lee MY, Koh JH, et al: Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property. Diabetes Res Clin Pract 83: 176-182, 2009.
9. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412, 1991.
10. Okada S, Shikata K, Matsuda M, et al: Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52: 2586-2593, 2003.
11. Ota T, Takamura T, Ando H, Nohara E, Yamashita H and Kobayashi K: Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Diabetologia 46: 843-851, 2003.
12. Ohkawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358, 1979.
13. Paoletti F, Mocali A and Aldinucci D: Superoxide-driven NAD(P)H oxidation induced by EDTA-manganese complex and mercaptoethanol. Chem Biol Interact 76: 3-18, 1990.
14. Agardh CD, Stenram U, Torffvit O and Agardh E: Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. J Diabetes Complications 16: 395-400, 2002.
15. Chen ZY, Yan MX, Cai DL, He BH, Chen H and Liu QS: Effect of SanQi on alcoholic fatty liver disease. Chin J Trad Chin Med Pharm 21: 614-616, 2006.
16. Sun W, Feng LY, Zhao ZJ, Liu TH and Yang MJ: Study on antioxidant effects and inhibition of podocyte apoptosis of PNS on DN rat. Chin J Trad Chin Med Pharm 26: 1062-1067, 2011.
17. Chen JX, Li AY, Wang ZY and Liu HX: Impact of Danshen powder injection on oxidative stress after the intervention in the patients with acute coronary syndromes of blood stasis type. World J Integr Trad West Med 6: 122-124, 2011.
18. Liu C, Min LQ, Ji ZS, Wang Q, Jia YJ and Li SY: Protective effects of salvia miltiorrhizae on oxidative stress in rats with focal cerebral ischemia. Chin J Clin Rehabil 10: 37-39, 2006.
19. Mo ZY, Liang D, Shitu Y, Huang PP and Chen XW: Effect of astragalus on oxidative stress status in primary nephrotic syndrome. Chin J Integr Trad Western Nephrol 5: 209-211, 2004.
20. Guan FY, Li H, Yu XX and Yang XJ: Effects of astragalus injection on myocardial cell damages due to oxidative stress. Chin J Rehabil Theory Pract 16: 830-832, 2010.
21. Liu ZJ, Li L, Wang J, Yan J and Liu CM: Antioxidant activities of polyphenol from Scrophularia ningpoensis Hemsl. Lishizhen Med Materia Medica Res 21: 796-798, 2010.
22. Shah IM, Mackay SP and McKay GA: Therapeutic strategies in the treatment of diabetic nephropathy - a translational medicine approach. Curr Med Chem 16: 997-1016, 2009